Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORM
2226
DELISTED
Owens Realty Mortgage, Inc.
ORM
| $1.83M | ﹤0.01% |
97,276
-38,997
| -29% | -$697K |
|
2227
Luxfer Holdings
LXFR
$459M
| $1.82M | ﹤0.01% |
103,221
-196,755
| -66% | -$4.47M |
|
2228
Modine Manufacturing
MOD
$9.95B
| $1.82M | ﹤0.01% |
168,322
-182,007
| -52% | -$2.32M |
|
2229
QuidelOrtho
QDEL
$1.02B
| $1.82M | ﹤0.01% |
37,254
-352,017
| -90% | -$21M |
|
2230
PUT
NatWest
NWG
$74.5B
| $1.82M | ﹤0.01% |
+301,786
| New | +$1.93M |
|
2231
Colliers International
CIGI
$5.34B
| $1.82M | ﹤0.01% |
+32,989
| New | +$2.1M |
|
2232
FerroAtlántica
GSM
$761M
| $1.81M | ﹤0.01% |
1,138,408
-3,968,849
| -78% | -$19M |
|
2233
MBIA
MBI
$256M
| $1.81M | ﹤0.01% |
202,756
-1,171,014
| -85% | -$11.1M |
|
2234
iShares S&P 100 ETF
OEF
$20.3B
| $1.81M | ﹤0.01% |
16,217
+2,305
| +17% | +$277K |
|
|
BID
2235
DELISTED
Sotheby's
BID
| $1.81M | ﹤0.01% |
45,480
+36,407
| +401% | +$1.48M |
|
2236
PUT
Lam Research
LRCX
$392B
| $1.8M | ﹤0.01% |
132,000
| – | – |
|
2237
Bank7 Corp
BSVN
$493M
| $1.79M | ﹤0.01% |
134,300
+48,313
| +56% | +$841K |
|
2238
Exponent
EXPO
$3.34B
| $1.79M | ﹤0.01% |
35,270
+9,107
| +35% | +$457K |
|
2239
Arbor Realty Trust
ABR
$944M
| $1.79M | ﹤0.01% |
177,495
-213,536
| -55% | -$2.48M |
|
2240
W.W. Grainger
GWW
$62.9B
| $1.78M | ﹤0.01% |
6,290
-310,880
| -98% | -$92.5M |
|
2241
iShares Gold Trust
IAU
$68.1B
| $1.78M | ﹤0.01% |
+72,235
| New | +$1.7M |
|
|
HRC
2242
PUT
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.77M | ﹤0.01% |
20,000
-140,000
| -88% | -$12.7M |
|
2243
Ceragon Networks
CRNT
$189M
| $1.77M | ﹤0.01% |
468,093
+79,725
| +21% | +$302K |
|
2244
PUT
Boston Scientific
BSX
$69.8B
| $1.77M | ﹤0.01% |
50,000
| – | – |
|
2245
Acco Brands
ACCO
$387M
| $1.76M | ﹤0.01% |
259,395
+48,102
| +23% | +$412K |
|
2246
Hilton Grand Vacations
HGV
$3.5B
| $1.76M | ﹤0.01% |
66,633
-529,180
| -89% | -$15.4M |
|
|
HSII
2247
DELISTED
Heidrick & Struggles
HSII
| $1.76M | ﹤0.01% |
56,347
-286,890
| -84% | -$9.39M |
|
2248
CALL
Eastman Chemical
EMN
$8.34B
| $1.75M | ﹤0.01% |
24,000
+8,100
| +51% | +$646K |
|
2249
Itron
ITRI
$4.33B
| $1.75M | ﹤0.01% |
36,997
-62,769
| -63% | -$3.32M |
|
2250
CALL
IQVIA
IQV
$43B
| $1.74M | ﹤0.01% |
15,000
+2,500
| +20% | +$303K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.